Clinical Trial Update: An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease [Phase 2]

View source ↗

Summary

The document reports the results of a Phase 2 trial evaluating the efficacy and safety of Inflabloc Cap in patients with Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Inflabloc Cap

Snippet

Sponsor: Inflabloc Pharmaceuticals | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED